151 related articles for article (PubMed ID: 28232728)
1. The road to precision oncology.
Biankin AV
Nat Genet; 2017 Feb; 49(3):320-321. PubMed ID: 28232728
[TBL] [Abstract][Full Text] [Related]
2. Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.
Araki D; Othus M; Walter RB; Sandhu V; Sandmaier BM; Becker PS; Appelbaum FR; Estey EH
Haematologica; 2015 Jul; 100(7):e254-6. PubMed ID: 25795719
[No Abstract] [Full Text] [Related]
3. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
4. The Changing Landscape of Treatment in Acute Myeloid Leukemia.
Koenig K; Mims A; Levis MJ; Horowitz MM
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-12. PubMed ID: 32239961
[TBL] [Abstract][Full Text] [Related]
5. Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?
Venditti A; Gale RP; Buccisano F; Ossenkoppele G
Leukemia; 2020 Apr; 34(4):963-965. PubMed ID: 32132654
[No Abstract] [Full Text] [Related]
6. Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: a continued, complicated conversation.
Menghrajani KN; Tallman MS
Blood Adv; 2018 Jan; 2(2):164. PubMed ID: 29365325
[No Abstract] [Full Text] [Related]
7. Acute Myeloid Leukemia: Update on Upfront Therapy in Elderly Patients.
Keiffer G; Palmisiano N
Curr Oncol Rep; 2019 Jun; 21(8):71. PubMed ID: 31250135
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual disease.
Appelbaum FR
Best Pract Res Clin Haematol; 2015; 28(2-3):133-40. PubMed ID: 26590770
[TBL] [Abstract][Full Text] [Related]
9. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
[TBL] [Abstract][Full Text] [Related]
10. Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.
Hemmati PG; Terwey TH; Na IK; le Coutre P; Jehn CF; Vuong LG; Dörken B; Arnold R
Eur J Haematol; 2015 May; 94(5):431-8. PubMed ID: 25220715
[TBL] [Abstract][Full Text] [Related]
11. Relapsed acute myeloid leukemia: why is there no standard of care?
Ravandi F
Best Pract Res Clin Haematol; 2013 Sep; 26(3):253-9. PubMed ID: 24309527
[TBL] [Abstract][Full Text] [Related]
12. A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia.
Fenwarth L; Thomas X; de Botton S; Duployez N; Bourhis JH; Lesieur A; Fortin G; Meslin PA; Yakoub-Agha I; Sujobert P; Dumas PY; Récher C; Lebon D; Berthon C; Michallet M; Pigneux A; Nguyen S; Chantepie S; Vey N; Raffoux E; Celli-Lebras K; Gardin C; Lambert J; Malfuson JV; Caillot D; Maury S; Ducourneau B; Turlure P; Lemasle E; Pautas C; Chevret S; Terré C; Boissel N; Socié G; Dombret H; Preudhomme C; Itzykson R
Blood; 2021 Jan; 137(4):524-532. PubMed ID: 32871585
[TBL] [Abstract][Full Text] [Related]
13. Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach.
Fuse K; Uemura S; Tamura S; Suwabe T; Katagiri T; Tanaka T; Ushiki T; Shibasaki Y; Sato N; Yano T; Kuroha T; Hashimoto S; Furukawa T; Narita M; Sone H; Masuko M
Cancer Med; 2019 Sep; 8(11):5058-5067. PubMed ID: 31305031
[TBL] [Abstract][Full Text] [Related]
14. Are we ready for precision medicine in acute myeloid leukemia?
Roboz GJ
Clin Adv Hematol Oncol; 2016 Aug; 14(8):582-4. PubMed ID: 27487100
[No Abstract] [Full Text] [Related]
15. Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderly.
Schiller GJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):437-8. PubMed ID: 24487045
[No Abstract] [Full Text] [Related]
16. Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Tallman MS; Wang ES; Altman JK; Appelbaum FR; Bhatt VR; Bixby D; Coutre SE; De Lima M; Fathi AT; Fiorella M; Foran JM; Hall AC; Jacoby M; Lancet J; LeBlanc TW; Mannis G; Marcucci G; Martin MG; Mims A; O'Donnell MR; Olin R; Peker D; Perl A; Pollyea DA; Pratz K; Prebet T; Ravandi F; Shami PJ; Stone RM; Strickland SA; Wieduwilt M; Gregory KM; ; Hammond L; Ogba N
J Natl Compr Canc Netw; 2019 Jun; 17(6):721-749. PubMed ID: 31200351
[TBL] [Abstract][Full Text] [Related]
17. Benefit of allogeneic transplantation in patients age ≥ 60 years with acute myeloid leukemia is limited to those in first complete remission at time of transplant.
Michelis FV; Messner HA; Atenafu EG; Kim DD; Kuruvilla J; Lipton JH; Uhm J; Loach D; Gupta V
Biol Blood Marrow Transplant; 2014 Apr; 20(4):474-9. PubMed ID: 24345422
[TBL] [Abstract][Full Text] [Related]
18. A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission.
Kurosawa S; Yamaguchi T; Miyawaki S; Uchida N; Kanamori H; Usuki K; Yamashita T; Watanabe M; Yakushiji K; Yano S; Nawa Y; Taguchi J; Takeuchi J; Tomiyama J; Nakamura Y; Miura I; Kanda Y; Takaue Y; Fukuda T
Blood; 2011 Feb; 117(7):2113-20. PubMed ID: 21106987
[TBL] [Abstract][Full Text] [Related]
19. Should patients with acute myeloid leukemia and measurable residual disease be transplanted in first complete remission?
Buccisano F; Walter RB
Curr Opin Hematol; 2017 Mar; 24(2):132-138. PubMed ID: 27930388
[TBL] [Abstract][Full Text] [Related]
20. Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.
Tamborero D; Dienstmann R; Rachid MH; Boekel J; Baird R; Braña I; De Petris L; Yachnin J; Massard C; Opdam FL; Schlenk R; Vernieri C; Garralda E; Masucci M; Villalobos X; Chavarria E; ; Calvo F; Fröhling S; Eggermont A; Apolone G; Voest EE; Caldas C; Tabernero J; Ernberg I; Rodon J; Lehtiö J
Nat Med; 2020 Jul; 26(7):992-994. PubMed ID: 32632195
[No Abstract] [Full Text] [Related]
[Next] [New Search]